We’re realists. We’re scientists. And, we’re believers that 3D cell modeling should be fast, scalable, and reproducible. That’s where RASTRUM™ comes in. Tap through the images here to see what sets our core technology apart. LEARN MORE: https://lnkd.in/gtXcqUyF #BiotechInnovation #3DCellModels #DrugDiscovery #InventiaLifeScience
Inventia Life Science
Biotechnology Research
Alexandria, New South Wales 11,241 followers
Advanced cell models made easy for high impact discovery
About us
Inventia Life Science is making advanced cell models easy for high impact discovery. The company’s strong foundation of fundamental research has led to the development of proprietary solutions to generate high-quality advanced cell models that are reproducible and highly consistent. Built by scientists for scientists, our intuitive solutions integrate seamlessly with existing workflows, whereas our wide range of biofunctional synthetic matrices and application-driven models make your desired assays possible.
- Website
-
http://www.inventia.life
External link for Inventia Life Science
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Alexandria, New South Wales
- Type
- Privately Held
- Founded
- 2013
- Specialties
- 3D cell culture, Cell-based assays, Biomedical research, Pre-clinical models, In vitro models, Cancer Models, Tissue models, Complex in vitro models, Drug discovery, Disease modelling, Advanced cell models, and Extracellular matrix
Locations
-
Primary
20-22 William Street
Alexandria, New South Wales 2015, AU
-
200 Powder Mill Rd
Suite 4805B
Wilmington, Delaware 19803, US
-
Cherrywood Business Park
Building 10, Block G
Loughlinstown, Co. Dublin, D18 T3Y1, IE
Employees at Inventia Life Science
-
Nigel Franklin
Inventia Life Sciences: Advanced Cell Models Made Easy
-
Dana Foreman
Passionate about Healthcare | Strategic Marketing Architect | Driving Business Advancement and Successful Commercialization Strategies
-
Dwayne Dexter, PhD
Director, Inventia Scientific Corp US || Passionate about science and people's success
-
Bob Groneman
Chief Product Officer
Updates
-
📅🖥️ Save the date for a webinar with SelectScience® on August 6th at 11AM EST! Join Dr. William Bernard and Dr. Martin Engel in our upcoming webinar as they reveal groundbreaking tools and methodologies for the generation of functional, scalable 2D and 3D co-culture models of the human brain for disease research and drug discovery. Don’t miss out on accelerating your drug discovery timelines! Reserve your spot now and receive a certificate of attendance. REGISTER: https://lnkd.in/e2mSA2Pz
-
🔬 Dive into the future of cell migration with our latest application note! Our scientists are utilizing the #RASTRUM™ Platform combined with 3D cell migration analysis in various matrix stiffness through live-cell tracking using non-invasive and invasive breast cancer cell lines. Read more and download at the link: https://lnkd.in/g9x-_i4m #CellResearch #CancerResearch #InventiaLifeScience
-
In this episode of #NewMatter, we're joined by Dwayne Dexter, PhD, and April Kloxin, Ph.D., to explore the latest in 3D cell model challenges and innovations. Tune in for insights on overcoming research hurdles, the advantages of 3D printing, and what lies ahead for biological modeling. Listen now on Spotify, Apple Podcasts, or via the link! 🎧🎙️ https://lnkd.in/gm5eBmuk #Podcast #BiotechInnovation #3DCellModels #DrugDiscovery #InventiaLifeScience
-
🌍 Exciting news for our European customers! 🌟 We're thrilled to announce our new office location at the Science Campus in Alderley Park, UK! This move is a significant step in our journey, allowing us to better serve our growing European customer base and immerse ourselves in the vibrant biotech community 🚀🔬 Stay tuned for more updates as we continue to innovate and grow together! 💡 #RASTRUM #PhenotypicCellModels #3dcellmodels #3dcellculture #drugdiscovery
-
Navigate cancer complexity with ease! Whether you're exploring the tumour microenvironment, developing the next generation of anti-cancer therapies, or modelling the interactions between immune and cancer cells, the RASTRUM Platform is your go-to solution. Key benefits of RASTRUM: 🌟 Tailored: Access a library of matrix composition and stiffness for a range of tissue types, mimicking the tumour microenvironment for realistic experimental outcomes. 🌟 Compatibility: Accommodate a range of cancer cell types and sensitive cell types, including patient-derived cells. 🌟 Flexibility: Mix and match different synthetic matrices, architectures and co-cultures to give you more control and create the tumour microenvironment to suit your research needs. 🌟 Scalability: Integrates seamlessly into existing workflows, ensuring efficiency and reproducibility, allowing researchers to focus on anti-cancer drug testing, and downstream analysis without compromise. 👉 Learn more about how the RASTRUM Platform can transform your cancer research: https://lnkd.in/gBkpuTgc Image details: A2780 ovarian cancer cells in 4.8 kPa RASTRUM Matrix after 7 days post-printing using cell painting. #CancerResearch #phenotypic3Dcellmodels #Cancer #RASTRUM #3Dcellmodels #3Dcellculture
-
An insightful presentation by UNSW's Chantal Kopecky from Prof Kris Kilian's team at the 14th International NanoMedicine Conference in Sydney. Chantal is ulitising the RASTRUM Platform to study cellular cancer plasticity in various 3D cancer cell models. Well done Chantal! 🎉 Watch this space for more updates on this trailblazing research! 👀 #CancerResearch #OzNanomed #NanoMedicine2024 #3DCancerModels #3Dcellculture
-
🚨 Hot off the press! 🚨 If you haven't heard already, the team at the University of Wollongong led by Ann-Katrin Piper and Marie Ranson have recently published their work on targeting EGFR and PI3K signalling pathways in metastatic gastric adenocarcinoma using circulating tumour cells (CTCs). The gastric cancer CTCs were cultured in 3D cell models including RASTRUM Matrices and compared to 2D cultures. The study showed the cells were highly responsive to PI3K-targeted drugs, with increased sensitivity in 3D cultures. Combining PI3K inhibitors with the EGFR inhibitor gefitinib showed strong synergy, significantly impairing cell invasion. Congrats to the team! Read the publication: https://lnkd.in/gqRAY6N9 #CancerResearch #GastricCancer #EGFR #PI3K #CTCs #3DcellCulture #3Dcellmodels
-
🎉 Celebrating 10,000 followers on LinkedIn! 🎉 A huge thank you to each of you for being part of our journey. Every follower represents a meaningful connection, a valued relationship, and a step forward in our mission to transform human health. A special shoutout to Ann-Katrin Piper for presenting her latest work on targeting EGFR and PI3K signaling pathways in metastatic gastric adenocarcinoma using circulating tumour cells. We’re thrilled to celebrate this milestone with such inspiring contributions! Read the paper here: https://lnkd.in/gqRAY6N9
-
Anyone can now reproducibly model the tumour environment with precision 🎉 Our Triple Matrix Model is designed to accurately recreate the complex interface between stroma and cancer tissue. The image below showcases three distinct cell types in a co-culture—cancer cells, fibroblasts, and endothelial cells—co-existing just as they do in real tissue. Our model features the intricate interface of the tumour environment (bottom section of image) and its surrounding tissue (top section of image). Achieved through the high precision of the RASTRUM Platform, this spatial organisation elevates the ability to create representative phenotypic cell models that will provide deeper, more relevant insights for your disease research. Learn more about how you can easily model complex biology with this tech note: https://lnkd.in/d39tSXpv Image details: 💛 Yellow = Endothelial cells 💙 Blue = Cancer cells and fibroblasts 💜 Purple = DAPI #TumorMicroenvironment #CancerResearch #Coculture #Fibroblasts #Stroma #Cancer #DrugDiscovery #phenotypicCellmodels #3Dcellculture #3Dcellmodels